{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:23:50Z","timestamp":1794029030542,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101063","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:43:25Z","timestamp":1784591005000},"page":"101063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CATS-BIT-ME Score: A Machine Learning and Conventional Risk Model for Prognosis in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"5","author":[{"given":"Chun-Ting","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Chia-Hui Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7492-2484","authenticated-orcid":false,"given":"Pei-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Cheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiing-Chyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.101063_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gastha.2026.101063_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.gastha.2026.101063_bib3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hep.32434","article-title":"Risk factors for HCC in contemporary cohorts of patients with cirrhosis","volume":"77","author":"Kanwal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101063_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.gastha.2026.101063_bib5","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.gastha.2026.101063_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/v15010126","article-title":"Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019","volume":"15","author":"Kee","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.gastha.2026.101063_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma","volume":"51","author":"Wu","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/srep42577","article-title":"The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma","volume":"7","author":"Hsieh","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2026.101063_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jfma.2019.09.003","article-title":"Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: a propensity score matching analysis","volume":"119","author":"Su","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.gastha.2026.101063_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/JCMA.0000000000000722","article-title":"Differential prognoses among male and female patients with hepatocellular carcinoma","volume":"85","author":"Liao","year":"2022","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.gastha.2026.101063_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib13","article-title":"The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.101063_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","article-title":"Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101063_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HEP.0000000000001026","article-title":"Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: the impact of successful antiviral treatment","volume":"81","author":"Celsa","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101063_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16237","article-title":"Gender different impacts of muscle mass and adipose tissue on patients with hepatocellular carcinoma undergoing surgical resection","volume":"45","author":"Lee","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.gastha.2026.101063_bib17","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000678","article-title":"Prognostic nutritional index as a prognostic factor for very early-stage hepatocellular carcinoma","volume":"15","author":"Ho","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101063_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2020.04.032","article-title":"A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma","volume":"73","author":"Serenari","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/liv.15487","article-title":"Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab","volume":"43","author":"Campani","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.gastha.2026.101063_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gastha.2026.101063_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jhep.2015.10.029","article-title":"Prognosis of hepatocellular carcinoma: assessment of eleven staging systems","volume":"64","author":"Liu","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jgh.12686","article-title":"Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma","volume":"30","author":"Wang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1355454","article-title":"Artificial intelligence in liver cancer research: a scientometrics analysis of trends and topics","volume":"14","author":"Rezaee-Zavareh","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.gastha.2026.101063_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3350\/cmh.2024.0103","article-title":"Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma","volume":"30","author":"Ho","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib25","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","article-title":"Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE","volume":"31","author":"Kong","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gastha.2026.101063_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000487407","article-title":"The prognosis of single large hepatocellular carcinoma was distinct from Barcelona clinic liver cancer stage A or B: the role of albumin-bilirubin grade","volume":"7","author":"Fang","year":"2018","journal-title":"Liver Cancer"},{"key":"10.1016\/j.gastha.2026.101063_bib27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.gastha.2026.101063_bib28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.20486","article-title":"Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score","volume":"40","author":"Kudo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101063_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/gut.2003.035055","article-title":"Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients","volume":"54","author":"Tateishi","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.101063_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2010.01.038","article-title":"A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei integrated scoring system","volume":"53","author":"Hsu","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib31","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101063_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators","volume":"28","author":"Manghisi","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101063_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MCG.0b013e31825ceeb5","article-title":"Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation","volume":"46","author":"Wu","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101063_bib34","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1245\/s10434-014-4221-5","article-title":"Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection","volume":"22","author":"Su","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gastha.2026.101063_bib35","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/apt.17438","article-title":"Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy","volume":"57","author":"Kao","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2026.101063_bib36","article-title":"The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: a meta-analysis","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2026.101063_bib37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/lt.25204","article-title":"Lymphocyte-to-monocyte ratio is a predictor of survival after liver transplantation for hepatocellular carcinoma","volume":"24","author":"Mano","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastha.2026.101063_bib38","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v27.i26.4104","article-title":"Hepatocellular carcinoma in patients with renal dysfunction: pathophysiology, prognosis, and treatment challenges","volume":"27","author":"Yeh","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101063_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality","volume":"33","author":"Na","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.gastha.2026.101063_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101063_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2026.101063_bib42","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","article-title":"Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma","volume":"76","author":"Calderaro","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3350\/cmh.2023.0287","article-title":"Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: a nationwide hepatitis C virus registry program","volume":"30","author":"Lu","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.gastha.2026.101063_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:24:05Z","timestamp":1794025445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001846"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101063","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CATS-BIT-ME Score: A Machine Learning and Conventional Risk Model for Prognosis in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101063"}}